The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Stuart A. Lipton

The Burnham Institute for Medical Research

The Salk Institute for Biological Studies

The Scripps Research Institute

and the University of California--San Diego

USA

[email]@burnham.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • The Burnham Institute for Medical Research, The Salk Institute for Biological Studies, The Scripps Research Institute, and the University of California--San Diego, USA. 2005 - 2007
  • Burnham Institute for Medical Research, University of California at San Diego, 10901 North Torrey Pines Road, La Jolla, USA. 2006
  • Center for Neuroscience and Aging, Burnham Institute, 10901 North Torrey Pines Road, La Jolla, USA. 2001 - 2005
  • The Scripps Research Institute, and the University of California, San Diego, La Jolla, USA. 2004

References

  1. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Lipton, S.A. Curr. Drug. Targets (2007) [Pubmed]
  2. Pathologically activated therapeutics for neuroprotection. Lipton, S.A. Nat. Rev. Neurosci. (2007) [Pubmed]
  3. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Lipton, S.A. Nat. Rev. Drug. Discov (2006) [Pubmed]
  4. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Lipton, S.A. Current. Alzheimer. Research (2005) [Pubmed]
  5. Comment on "S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function". Lipton, S.A., Nakamura, T., Yao, D., Shi, Z.Q., Uehara, T., Gu, Z. Science (2005) [Pubmed]
  6. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. Lipton, S.A. J. Alzheimers Dis. (2004) [Pubmed]
  7. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. Lipton, S.A. NeuroRx (2004) [Pubmed]
  8. Cysteine regulation of protein function--as exemplified by NMDA-receptor modulation. Lipton, S.A., Choi, Y.B., Takahashi, H., Zhang, D., Li, W., Godzik, A., Bankston, L.A. Trends Neurosci. (2002) [Pubmed]
  9. Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Lipton, S.A., Bossy-Wetzel, E. Cell (2002) [Pubmed]
  10. Retinal ganglion cells, glaucoma and neuroprotection. Lipton, S.A. Prog. Brain Res. (2001) [Pubmed]
 
WikiGenes - Universities